Protecting Patients with Chemotherapy Safety Strategies
June 2011 - Vol. 8 No. 6 - Page #12

Q&A with Sylvia Bartel, RPh, MHP
Vice President, Pharmacy Services

Dana-Farber Cancer Institute

Pharmacy Purchasing & Products: What are the medication safety risks associated with chemotherapy agents? 
Sylvia Bartel: While the benefits of chemotherapy agents are well known, they are considered high-risk medications and just a slight variability in dosage can potentially lead to a tragic outcome. Even when administered appropriately, adverse reactions—such as low blood counts, fatigue, nausea, and vomiting—are expected. 

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.